MDT — Medtronic plc
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Dividends
Measured signals that fired on MDT
| date | signal | measured base rate |
|---|---|---|
| 2026-08-13 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-08-11 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-28 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-15 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-07-06 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-06-03 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-03 | Thompson Kweli EVP & President, Neuroscience | Grant or award | 6.9K | 0.00 | 0 |
| 2026-08-03 | Walter Matthew R. SVP, Chief HR Officer | Grant or award | 5.8K | 0.00 | 0 |
| 2026-08-03 | Pieton Thierry EVP & Chief Financial Officer | Grant or award | 11.5K | 0.00 | 0 |
| 2026-08-03 | Blomquist Denise L. Chief Accounting Officer | Grant or award | 2.3K | 0.00 | 0 |
| 2026-08-03 | Marinaro Michael EVP, Pres MedSurg and Americas | Grant or award | 11.0K | 0.00 | 0 |
| 2026-08-03 | Marinaro Michael EVP, Pres MedSurg and Americas | Grant or award | 46.1K | 0.00 | 0 |
| 2026-08-03 | KIIL HARRY SKIP EVP & President Cardiovascular | Grant or award | 9.2K | 0.00 | 0 |
| 2026-08-03 | Martha Geoffrey Chairman and CEO | Grant or award | 41.5K | 0.00 | 0 |
| 2026-08-03 | Quinn Michelle EVP, GC and Secretary | Grant or award | 6.3K | 0.00 | 0 |
| 2026-07-31 | Martha Geoffrey Chairman and CEO | Shares withheld for tax | 15.8K | 85.39 | 1.4M |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 9.8B | 113.2M |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.2B | 83.3M |
| STATE STREET CORP | 5.4B | 61.7M |
| JPMORGAN CHASE & CO | 4.4B | 51.0M |
| Capital Research Global Investors | 3.6B | 41.9M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.9B | 33.5M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.7B | 21.4M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5B | 28.7M |
| BANK OF AMERICA CORP /DE/ | 2.3B | 26.0M |
| MORGAN STANLEY | 1.8B | 20.7M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| DEFA14A | 2026-08-17 | — | on EDGAR ↗ |
| DEF 14A | 2026-08-17 | 2026-10-15 | on EDGAR ↗ |
| 4 | 2026-08-04 | 2026-07-31 | on EDGAR ↗ |
| 4 | 2026-08-04 | 2026-07-31 | on EDGAR ↗ |
| 4 | 2026-08-04 | 2026-07-31 | on EDGAR ↗ |
| 4 | 2026-08-04 | 2026-08-03 | on EDGAR ↗ |
| 4 | 2026-08-04 | 2026-08-03 | on EDGAR ↗ |
| 4 | 2026-08-04 | 2026-07-31 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
Others in Healthcare
Ask the AI about MDT
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →